Molecular autopsy for fetal structural anomaly: diagnostic and clinical utility of multidisciplinary team approach
Authors:
- 12 August 2024
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 64 (3) , 381-387
Abstract
Objective: In the West Midlands regional genetics service, cases of perinatal death with a possible genetic diagnosis are evaluated by the perinatal pathology genetic multidisciplinary team (MDT). The MDT assesses autopsy findings and suggests appropriate genomic assessment. The objective of this retrospective service evaluation was to determine the clinical utility of the MDT in assessing perinatal deaths associated with structural anomaly. This is the first evaluation since the introduction of whole‐genome and whole‐exome sequencing in routine clinical care.Methods: This was a retrospective service evaluation including all cases of perinatal death with an associated structural anomaly and suspected genetic etiology that underwent perinatal MDT assessment between January and December 2021. All cases received a full or partial postmortem examination and at least a chromosomal microarray analysis. Demographic characteristics, phenotype, genotype, MDT recommendations, diagnoses, outcomes and impact of postmortem analysis and genetic testing data were collected from patient case notes.Results: Overall, 123 cases were discussed at the MDT meetings in 2021. Genetic evaluation was recommended in 84 cases and accepted in 64 cases. A range of genetic tests were requested according to indication and availability. Thirty diagnoses were made in 29 cases from 26 unrelated families. The diagnostic yield was 24% (29/123) in all cases or 45% (29/64) in cases with a suspected genetic diagnosis who underwent genetic testing. Postmortem examination provided clinically actionable phenotypic data in 79% of cases. A genetic diagnosis enabled accurate recurrence risk counseling and provision of appropriate follow‐up, including prenatal testing and preimplantation diagnosis for patients with inherited conditions.Conclusions: Genomic testing was a clinically useful addition to (but not a substitute for) postmortem examination in cases of perinatal death associated with structural anomaly. The MDT approach helped assess cases and plan appropriate follow‐up. Expedited whole‐genome sequencing or panel‐agnostic analysis were most appropriate for heterogeneous presentations. This broad approach can also expand knowledge of prenatal phenotypes and detect novel disease genes, and should be a priority in future research. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.Keywords
This publication has 28 references indexed in Scilit:
- Prenatal diagnosis of CLCN4‐related neurodevelopmental disorder in fetuses with congenital brain anomaliesPrenatal Diagnosis, 2023
- Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta‐analysisPrenatal Diagnosis, 2022
- Fetal hydrops and the Incremental yield of Next‐generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta‐analysisUltrasound in Obstetrics & Gynecology, 2021
- Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort studyThe Lancet, 2019
- Diagnosis of lethal or prenatal‐onset autosomal recessive disorders by parental exome sequencingPrenatal Diagnosis, 2017
- Correlation between fetal autopsy and prenatal diagnosis by ultrasound: A systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2017
- Supporting women, families, and care providers after stillbirthsThe Lancet, 2016
- Stillbirths: economic and psychosocial consequencesThe Lancet, 2016
- Epidemiology of multiple congenital anomalies in Europe: A EUROCAT population‐based registry studyBirth Defects Research Part A: Clinical and Molecular Teratology, 2014
- The Prevalence of Congenital Anomalies in Europe2010